DECEMBER 2026 SEEDWORLD.COM / 29 The Only Return that Really Counts As an industry, we also need to be more disciplined about how we discuss performance. It's easy to talk about a five-, six- or eight-bushel yield response. Those numbers need to be backed by extensive evidence, of course. Even then, they mean relatively little without knowing what the grower paid to achieve them. Take PathoShield in U.S. corn. At our current pricing, a grower needs approximately one additional bushel per acre to cover the product cost. Historically, we've seen four- to five-bushel respons es in greater than 75% of our trials, with a typical return of roughly five dollars for every dollar invested. We have more than 7,500 field trials across our portfolio, including our own research, university collaborations and com mercial grower demonstrations. Our technologies have been used on more than 15 million acres globally. Even with that experi ence, I wouldn't suggest that each of our solutions works equally well everywhere. We continue to focus on understanding which environments, crops and production conditions favour particular microorganisms, and be transparent about where growers should expect the greatest benefit. Biologicals should complement conventional crop protection programs, providing additional modes of action and opportunities to protect yield. They don't need to replace every existing tool to justify their place in the program. Finding the Next Generation of Biologicals ENAI (from Endophytes and Artificial Intelligence) became in dependent from Indigo Agriculture in August 2026. While we’re a new entity, the scientific and commercial foundation behind us has been built over more than a decade. Indigo operated across biologicals, sustainability and carbon markets. Separating those businesses allows us to concentrate our resources on microbial innovation, particularly endophytic crop protection, while maintaining the Indigo heritage of innovation. We have approximately 36,000 microbial strains in our propri etary library and more than 32 million data points. Our challenge now is extracting more value from all that information. Through Flagship's broader innovation ecosystem, we're utiliz ing AI and machine-learning with our proprietary intelligence to screen microbial strains against specific disease, insect and nematode targets, accelerating the identification of promising candidates. Consistency has been one of the biggest challenges with bio logicals, and an area AI can make a real difference. The better we understand the conditions under which a particular microorgan ism performs, the more precisely we can match products to crops, environments and grower needs. That gives seed companies and retailers more confidence in what they're recommending, and growers a better chance of seeing the return they expect. I'm especially interested in what this means for new biofungi cides, bioinsecticides and bionematicides. Resistance continues to put pressure on existing crop protection chemistry, while rela tively few genuinely new modes of action are reaching the mar ket. Growers need additional tools, and the seed industry has an important role in delivering them. Where Seed Companies Fit ENAI’s independence also creates opportunities for collabora tion. We have a branded commercial portfolio, but we also work through private label distribution, retail, agricultural chemical and seed industry partners. We're interested in collaborating wherever our technology can strengthen an existing offering or help bring a new solution to market. Seed companies are particularly interesting partners because seed is such a practical delivery system for endophytic microor ganisms. There's potential to explore how biologicals fit within a differentiated seed offering, how particular microorganisms perform across crops and environments, and how we can develop more targeted solutions together. We're already active commercially in North America, South America and Europe, and we're exploring opportunities beyond corn and soybeans, including potatoes, strawberries, lettuce and other high-value crops. What excites me most is connecting the discovery work happening in our laboratories with the commer cial experience and market access of our partners. Over the next five to 10 years, resistance and regulatory pres sures will continue to challenge conventional crop protection programs. I want biologicals to earn a permanent place in that conversation. After 25 years in this industry, I've become pretty demanding about what earns a place in a grower's program. The science has to hold up, the economics have to make sense, and the product has to work within the realities of commercial agriculture. I've seen what endophytes can deliver on all three fronts, and I'm excited about how much further we can take this technology. Above: Nemora biological nematicide bacteria (glowing points) swarm soybean cyst nematode eggs (dark ovals). Left: M46 microbial biostimulant improves water and nutrient use efficiency through Coniochaeta nivea, a fungus whose hyphae (green) act as additional corn root hairs (root cells in red).
View this content as a flipbook by clicking here.